Disruptive Medical Tech Access for Life offers the JEM smart device as a revolutionary solution for safe venous access and AV fistula preservation, presenting a compelling value proposition for dialysis centers seeking to reduce access-related complications and associated costs.

Home Care Enablement The JEM device enables safer cannulation by less skilled caregivers and even patients themselves, opening sales opportunities with home dialysis programs, patient education partners, and home health providers looking to expand home-based treatment.

Data Driven Care Embedded sensing and real-time monitoring create a data stream on vascular health and dialysis process quality, appealing to clinics and payers interested in outcome tracking, early intervention, and cost containment.

Early Stage Investment With revenue under one million and funding of 156K, targeted outreach to strategic investors, grant programs, and accelerator partners in medical devices can help scale manufacturing, regulatory clearance, and go-to-market efforts.

Strategic Partnerships Potential collaborations with vascular access clinics, dialysis chains, and hospital systems to pilot the JEM device, plus integration opportunities with existing digital health platforms and EMR workflows for seamless adoption.